| mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
-0.23 |
4e-08 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-06 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
5e-06 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.24 |
7e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-06 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |